Close Menu

NEW YORK (GenomeWeb) – Genetic variants in the PCSK9 gene have the same effect on cardiovascular disease and diabetes risk as variants within the HMGCR gene, which encodes the target of lipid-lowering statins.

According to an international team of researchers, this suggests that therapies targeting PCSK9 should have similar effects as statins on cardiovascular events, but with the same potential risk of developing diabetes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The New York Times reports on an effort to address in high school biology classes misconceptions regarding race and genetics.

60 Minutes speaks with Harvard's George Church about tackling the effects of aging and more.

In PLOS this week: rare alterations in Timothy syndrome, analysis of twins' gut microbiomes, and more.

GenomeWeb reports that Veritas Genetics is suspending its US operations.

Jan
28
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.